Verification evidence is still being completed.
PDF / print export
TFTAK
Tallinn, Estonia
- Verified lead
- Martin Lall, MSc
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Bioprocess Optimization, Microbiome Research, Alternative Proteins, and Applied Biotechnology Services
- Review cycle
- May 2026
- Full address
- Mäealuse 2/4, 12618 Tallinn, Estonia
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official TFTAK team and about page confirming the current operating lead in Tallinn.
- Editorial note
- TFTAK is published as an Estonia research anchor because its official team page clearly confirms Martin Lall as CEO, the Tallinn operating site, and a biotech-focused applied-research and pilot-scale platform.
Bioprocess Optimization, Microbiome Research, Alternative Proteins, and Applied Biotechnology Services
Business Registry ID 11930972, VAT EE101379478, Private applied-research organization
TFTAK is published as an Estonia research anchor because its official team page clearly confirms Martin Lall as CEO, the Tallinn operating site, and a biotech-focused applied-research and pilot-scale platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
TFTAK runs bioprocess optimization, microbiome research, and pilot-scale product development in Tallinn, Estonia.
- Lead
- Martin Lall, MSc (verified ↗)
- Address
- Mäealuse 2/4, 12618 Tallinn, Estonia (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Applied contract research and pilot-scale biotechnology platform
- Capabilities
- Bioprocess Optimization · Microbiome Research · Pilot-Scale Product Development
- Founded
- 2006
- Headcount
- 51-200
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Martin Lall, MSc
Chief Executive Officer
Full addressMäealuse 2/4, 12618 Tallinn, Estonia
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official TFTAK team and about page listing the Mäealuse 2/4 Tallinn address.
Open sourceApplied contract research and pilot-scale biotechnology platform
Tallinn, Estonia. Bioprocess Optimization, Microbiome Research, Alternative Proteins, and Applied Biotechnology Services. Review completed on 21 Mar 2026.
Estonian business registry and contract research governance
Business Registry ID 11930972, VAT EE101379478, Private applied-research organization
Bioprocess Optimization, Microbiome Research, Alternative Proteins, and Applied Biotechnology Services
TFTAK is published as an Estonia research anchor because its official team page clearly confirms Martin Lall as CEO, the Tallinn operating site, and a biotech-focused applied-research and pilot-scale platform.
Editorial note
TFTAK is published as an Estonia research anchor because its official team page clearly confirms Martin Lall as CEO, the Tallinn operating site, and a biotech-focused applied-research and pilot-scale platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Bioprocess Optimization
Microbiome Research
Pilot-Scale Product Development
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Biotech research laboratories
Analytics and metagenomics support
Pilot-plant equipment
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is TFTAK located?
- TFTAK operates from Mäealuse 2/4, 12618 Tallinn, Estonia, Tallinn, Estonia.
- Who runs TFTAK?
- TFTAK is led by Martin Lall, MSc, Chief Executive Officer. Verified 21 Mar 2026.
- What does TFTAK do?
- TFTAK runs bioprocess optimization, microbiome research, and pilot-scale product development in Tallinn, Estonia. Core capabilities: Bioprocess Optimization, Microbiome Research, Pilot-Scale Product Development.
Editorial context
Related technical briefs
Briefs that name Tallinn as a covered market or city.